Kayentis’ EUR 5 Million Fundraising

Chammas & Marcheteau advised Kayentis on its fundraising. Kayentis, a French software solutions provider for pharmaceutical clinical trial management, has recently raised €5 million from its existing investors...

This content is for Standard 1 Year members only.
Login Join Now

Xelya’s OBO

Chammas & Marcheteau advised Xelya and the sellers in the framework of the OBO. Goodwin and MB Avocats advised Parquest. The founders of Xelya, together with...

This content is for Standard 1 Year members only.
Login Join Now

ITEN’s €80 Million Fundraising

Chammas & Marcheteau advised SEB Alliance on the transaction. Goodwin Paris advised ITEN. UGGC Avocats advised Bpifrance. ITEN, the French specialist in Li-ion ceramic technology, announced its...

This content is for Standard 1 Year members only.
Login Join Now